NDC 59584-140

Spherusol

Coccidioides Immitis Spherule-derived Skin Test Antigen

Spherusol is a Intradermal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nielsen Biosciences, Inc.. The primary component is Coccidioides Immitis Spherule.

Product ID59584-140_1ed6fcd5-4d38-4d43-8941-c4d90e6733e2
NDC59584-140
Product TypeHuman Prescription Drug
Proprietary NameSpherusol
Generic NameCoccidioides Immitis Spherule-derived Skin Test Antigen
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL
Marketing Start Date2011-07-29
Marketing CategoryBLA / BLA
Application NumberBLA125354
Labeler NameNielsen BioSciences, Inc.
Substance NameCOCCIDIOIDES IMMITIS SPHERULE
Active Ingredient Strength13 ug/mL
Pharm ClassesSkin Test Antigen [EPC],Cell-mediated Immunity [PE],Antigens, Fungal [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 59584-140-01

1 mL in 1 VIAL, MULTI-DOSE (59584-140-01)
Marketing Start Date2020-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59584-140-01 [59584014001]

Spherusol INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125354
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2011-07-29

Drug Details

Active Ingredients

IngredientStrength
COCCIDIOIDES IMMITIS SPHERULE12.7 ug/mL

OpenFDA Data

SPL SET ID:77108624-4771-4886-a3e2-b2625c444d1b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1666441
  • 1666446
  • Pharmacological Class

    • Skin Test Antigen [EPC]
    • Cell-mediated Immunity [PE]
    • Antigens
    • Fungal [CS]

    Trademark Results [Spherusol]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SPHERUSOL
    SPHERUSOL
    77926203 4195007 Live/Registered
    NIELSEN BIOSCIENCES, INC.
    2010-02-02

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.